All the chemicals were purchased from either of the following company: Sigma Aldrich, Alfa Aesar, Fischer Scientific, TCI chemicals, Merck, SD fine chemicals and Spectrochem, unless mentioned specifically. TCO-PEG-NHS ester was purchased from Click Chemistry Tools (cat. no. A137).
Synthesis of CB[7]-OH: CB [7] has been prepared and purified by following literature reported protocols 1,2 and characterized by 1 H NMR and HRMS. Next, mono-hydroxylation of CB [7] has been done by following a literature reported procedure with some modification 3 . CB [7] (250 mg, 0.215 mmol) was taken in a 50 ml quartz tube. It was dissolved in 40 ml solution of miliQ water and 10 M HCl solution (1/1 vol. %) under argon atmosphere. Sample was sonicated for a brief period to ensure all the CB [7] is solubilized before the addition of a solution of hydrogen peroxide (49 µl from 30% solution, 0.215 mmol). Then the solution was subjected to UV irradiation at wavelength of 250-400 nm (450 W) under vigorous stirring condition for 7.5 h. After that, the acidic solution was evaporated using rotary evaporator upto 2 ml and 250 ml methanol was added to it. The resulted precipitate was allowed to settle down for overnight. Next, the supernatant was decanted and remaining volume was centrifuged at 5500 rpm to get a light-yellow colored precipitate. 
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Synthesis of CB[7] conjugated antibody:
1. Secondary antibodies (Donkey anti-Rat, Donkey anti-Mouse, Donkey anti-rabbit and Goat anti-Mouse) were buffer exchanged by Zeba spin column pre-equilibrated with PBS containing 10% 1M NaHCO 3 .
2. The concentration of the antibody was measured and used for the conjugation with tetrazine.
3. Buffer exchanged secondary antibody (150 µg, 1x10 -3 µmol) was first taken in 1.5 ml micro centrifuge tube. 5. The reaction was incubated at room temperature for 2 h.
6. After that tetrazine conjugated antibody was purified by Zeba spin column (pre-equilibrated with PBS).
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7. CB[7]-PEG-TCO (21.2 µg, 6.5 µl from 3.33 mg ml −1 stock solution in H 2 O, 12.5×10 -3 µmol)
was added to antibody-tetrazine (75 µg, 5×10 -4 µmol) solution and the reaction mixture was stirred at room temperature for overnight to prepare CB [7] conjugated antibody through TCOtetrazine ligation. 8 8. CB [7] conjugated antibody was characterized by MALDI mass spectrometry. MALDI mass spectrum has been shown in Fig. S5 .
Synthesis of TCO conjugated antibody:
1. Secondary antibodies (donkey anti-rabbit, donkey anti-mouse, donkey anti-rat) was buffer exchanged by Zeba spin column pre-equilibrated with PBS containing 10% 1M NaHCO 3 .
2. The concentration of the antibody was measured and used for the conjugation with TCO .
3. Buffer exchanged secondary antibody (150 µg, 1x10 -3 µmol) was first taken in 1.5 ml micro centrifuge tube. 
MALDI−MS analysis for characterization of antibody-CB[7] conjugate
Antibodies (1 µl) after desalting through Zeba spin column (~ 1 mg.ml -1 in miliQ water) was taken in micro centrifuge tube. 1 µl of Sinapinic acid (10 mg.ml -1 in 50:50 water (0.1% TFA)/acetonitrile) was mixed with the antibodies. The mixed solution was placed onto a MALDI plate and allowed to dry at room temperature for analysis. MALDI−MS analysis was performed using a Bruker autoflex system.
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Figure S5: MALDI−MS spectra of free antibody and CB [7] conjugated goat anti-mouse secondary antibody.
Mass shift after conjugation was used to calculate the degree of CB [7] conjugation. We estimated an average of six CB [7] molecules attached with a single antibody. Mass shift after conjugation was used to calculate the degree of TCO conjugation. We estimated an average of fifteen numbers of TCO was attached with a single antibody.
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Synthesis of CB[7] conjugated Phalloidin:
Scheme S2. Synthetic scheme for preparation of CB [7] conjugated phalloidin.
1. Amino phalloidin (120 µg, 60 µl from 2 mg ml −1 stock solution in dry DMF, 0.1523 µmol) was taken in 1.5 ml micro centrifuge tube.
2. 5 µl DMF solution containing 0.106 µl Et 3 N was added to it.
3. 30.34 µl Tetrazine-NHS ester 9 (from a stock solution of 10 mg ml −1 in DMF, 0.7615 µmol) was added to it and the reaction was stirred at room temperature for 3 h.
4. After the reaction, the reaction mixture was diluted using 120 µl of mili Q water and injected to HPLC for purification using water/acetonitrile containing 0.1% TFA as eluent. The purity of the isolated compound was again analysed by HPLC (see Fig. S8 ). 0.076 µmol) was added to it and stirred at room temperature for overnight to prepare CB [7] conjugated phalloidin .
After purification
7. CB [7] conjugated phalloidin was then used for imaging of F-actin. 
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Synthesis of DBCO conjugated Phalloidin:
Scheme S3. Synthetic scheme for preparation of DBCO conjugated phalloidin.
1. Amino phalloidin (20 µg, 10 µl from 2 mg ml −1 stock solution in dry DMF, 0.0254 µmol) was taken in 0.5 ml micro centrifuge tube.
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2. 5 µl DMF solution containing 0.018 µl Et 3 N was added to it.
3. 3.6 µl DBCO NHS ester (from a stock solution of 25 mg ml −1 in DMF, 0.1270 µmol) was added to it and the reaction was stirred at room temperature for 3 h.
4. After the reaction, the reaction mixture was diluted using 80 µl of mili Q water and injected to HPLC for purification using water/acetonitrile containing 0.1% TFA as eluent. The purity of the isolated compound was again analysed by HPLC (see Fig. S9 ). 
After
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Scheme S4. Synthetic scheme for preparation of thiol modified 1-Adamantylamine (ADA)
Synthesis of compound 1
Mono tosylated tetraethylene glycol was synthesized following reported protocol with some modifications. 10 Tetra ethylene glycol (10 g, 51.22mmol) was dissolved in 130 ml acetonitrile in 250 ml RB Flask and Triethyl amine (7.13 ml, 51.22mmol) was added to it. Tosyl chloride (9.76 g, 51.22mmol), dissolved in 20 ml acetonitrile was added drop wise from dropping funnel over 1 h, keeping the reaction mixture at 0 o C. After addition, the reaction mixture was stirred at room temperature for 14h. During the reaction, a white precipitate of Triethyl ammonium hydrochloride was formed. After completion of reaction, the precipitate was filtered and washed with acetonitrile.
The acetonitrile was evaporated and purified using flash silica (230-400 mess) column (eluent:
Hexane/ethyl acetate gradient elution from 0 to 80%). TEG-mono-OTs was obtained as colourless oil (6.019 g, 35%). R f =0.375 (EtOAc/Hexane: 7:3). Ditosylated derivative was formed as a side product 
Synthesis of compound 2
A solution of NaOH (0.864 g, 21.6 mmol) in water (8 ml) was added to a solution of triphenylmethanethiol (3.98 g, 14.402 mmol) in a mixture of EtOH/toluene (1:1 v/v, 50 ml). The
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mono tosylated product (compound 1, 5.019 g, 14.402mmol) was dissolved in a second solution of EtOH/toluene (1:1 v/v, 50 ml), which was then added to the Triphenylmethanethiol mixture in one portion. The reaction mixture was stirred for 18 hours at RT. After completion of reaction (monitored by TLC) the reaction mixture was poured into a saturated solution of NaHCO 3 (20 ml) and extracted with Et 2 O (3 × 40 ml). The combined organic layers were washed with brine (3 × 40 ml), dried over 
Synthesis of compound 3
A solution of Trt-TEG-OH (5. 
Synthesis of compound 4
Adamantane amine hydrochloride (176.2 mg, 0.9386 mmol) and potassium carbonate (260 mg, 1.8772 mmol) and Trt-TEG-Oms (500 mg, 0.9386 mmol) were dissolved in 2 ml of DMF placed in a 10 ml RB flask. The reaction mixture was heated to 85 o C and stirred for 12h. After completion of reaction (monitored by TLC), the reaction mixture was cooled down at room temperature. 10 ml Methanol was added to the reaction mixture and the solid ppt was filtered off and filtrate was concentrated using rotary evaporator. 20 ml water was added to the crude product and product was extracted using ether (3x2 ml) from aqueous layer. Organic layer was dried over Na 2 SO 4 and purified
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by Flash silica column chromatography (Eluent: gradient eluent of 0-5% methanol in DCM v/v).
Yield 155 mg (0.2647 mmol, 65%). R f = 0.34 (eluent: DCM/MeOH: 19:1). 1 
Synthesis of compound 5
Trt-TEG-ADA (150mg, 0.2560 mmol) was dissolved in ml Dry DCM in 10 ml RB flask. The solution was purged with nitrogen and an excess of trifluoro acetic acid (TFA, 394µL, 5.12 mmol) was added. During the addition period of TFA the color of the solution was turned to yellow. Subsequently, triisopropylsilane (TIPS, 262µL, 1.28 mmol) was added to the reaction mixture and the color of mixture slowly recovered to colorless. The reaction mixture was allowed to stir at room temperature for 6 h under nitrogen atmosphere.
The volatile components (solvent, TFA and TIPS) were then distilled off under reduced pressure. The pale-yellow residue was purified by washing with hexane (10 ml Fig. S15 and S16 respectively. 
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Scheme S5. Synthetic scheme for preparation of ADA conjugated fluorophores. [M+H] + . HRMS spectrum of Cy5-maleimide is shown in Fig. S17 .
Synthesis of Cy5-Maleimide
Synthesis of ADA-Cy5
A stock solution of SH-TEG-ADA (22.22 µg, 50 µL from 0.9 mg ml -1 stock solution in PBS (pH 7.4), 0.1314 µmol) was added to the solution and stirred for overnight at room temperature. After that the reaction mixture was directly injected in HPLC for purification to yield ADA-Cy5 (90% from HPLC chromatogram 2+ . HRMS spectrum of ADA-Cy5 is shown in Fig. S18 .
Synthesis of Rhodamine-Maleimide
N-(2-aminoethyl) maleimide hydrochloride (804 µg, 80.4 µl from 10 mg ml −1 stock solution in DMF, 3.79 µmol) was dissolved in 50 µl dry DMF in a 1.5 ml glass vial. Triethyl amine (1.32 µl from 100 µl ml −1 stock solution in DMF, 9.48 µmol) was added to it. Then Rhodamine NHS ester (2 mg, 3.79
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µmol) dissolved in 100 µL DMF was added to it and the reaction mixture was stirred at room temperature for 12 h. After that the reaction mixture was diluted to 1 ml using Mili Q water and purified by reverse phase column chromatography using Biotage @ SNAP C18 cartridge (eluent: a gradient elution using acetonitrile/water from 0 to 100%). The blue colored eluent from the column was collected, concentrated and lyophilized to yield Rhodamine maleimide (1.4 mg, 68%, a blue HRMS spectrum of Rhodamine-maleimide is shown in Fig. S19 . 
Synthesis of ADA-Rhodamine
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Synthesis of Rhodamine-Tetrazine conjugate
Rhodamine NHS ester (500 µg, 0.947 µmol) was taken in 50 µl DMSO, amino tetrazine (196 µg, 40 µl from 4.9mg.ml -1 in DMSO 0.947 µmol) and 6.2 µL triethylamine (10% in DMSO) were added to it. The reaction mixture was allowed to stir at dark for 3 h at room temperature. After that the product was purified by reverse phase HPLC to yield Rhodamine tetrazine conjugate (90% from HPLC chromatogram). HRMS: ESI-MS: Calculated m/z 600.2359 [M+H] + , found 600.2277 [M+H] + . HRMS spectrum of Rhodamine-Tz is shown in Fig. S21 .
Synthesis of Cy5-Tetrazine conjugate
Cy5-NHS ester (250 µg, 0.328 µmol) was taken in 50 µl DMSO, amino tetrazine (300 µg, 30 µl from 10 mg.ml -1 in DMF 0.656 µmol) and 1 µL triethylamine (10% in DMF) were added to it. The reaction mixture was allowed to stir at dark for 3 h at room temperature. After that the product was purified by reverse phase HPLC to yield Cy5-tetrazine conjugate (90% from HPLC chromatogram). HRMS: Fig. S23 and S24b). 
ESI
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DNA-PEG 2 -maleimide
DNA-NH 2 (10 nmol, 10 µl from 1 mM stock in water) was taken in a micro centrifuge tube. 1.3 µl 10× PBS was added to it. Maleimide-PEG 2 -succinimidyl ester (42.54 µg, 100 nmol, 1.7 µl from 25 mg.ml -1 stock in DMF) was added to it and stirred at room temperature for 3 h. The conjugated product was purified by reversed phase HPLC after passing through Zeba spin column. The purified product was lyophilized and finally dissolved in PBS for ADA conjugation.
DNA-ADA conjugate
DNA-PEG 2 -maleimide (5 nmol, 10 µl from 500 nM stock in PBS) was taken in a micro centrifuge tube. ADA-PEG-thiol (34.35 µg, 100 nmol, 17.18 µl from 2 mg.ml -1 stock in PBS) was added to it and stirred at room temperature for 12 h. The conjugated product was purified by reversed phase HPLC. The purified product was lyophilized and characterized by MALDI mass spectrometry (Fig.   S25 ).
Synthesis of DNA-Atto 655 conjugate
DNA-NH 2 (15 nmol, 15 µl from 1 mM stock in water) was taken in a micro centrifuge tube and diluted to 55 µl using water. 8 µl 1M NaHCO 3 was added to it. Atto 655 NHS ester (33.2 µg, 37.5 nmol, 16.6 µl from 2 mg.ml -1 stock in DMF) was added to it and stirred at room temperature for 12 h.
The conjugated product was purified by reversed phase HPLC after passing through Zeba spin column. The purified product was lyophilized and finally stored in water for DNA−PAINT imaging.
MALDI mass spectrometry analysis of DNA-ADA conjugate
ADA conjugated DNA (1 µl, 100 µM in miliQ water) was taken in a micro centrifuge tube. 4-hydroxy picolinic acid (10 mg.ml -1 dissolved in 50:50 water/acetonitrile, 1 µl) was mixed with it. The mixed solution was plated onto the MALDI plate and allowed to dry at RT from analysis. Fluorescence intensity was measured from five different regions of microtubules and average intensity is shown in the plot. Scale bars: 2 µm (a-e). 
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CB[7]-ADA mediated labeling of microtubule in variable pH conditions:
Microtubules in HeLa cells were targeted using CB [7] conjugated antibody against beta-tubulin.
CB [7] labeled cells were incubated with ADA conjugated cy5 fluorophores (Conc. = 100 nM) in different pH solutions ranging from 4.5 to 9.2. The compositions of buffers used in this study are mentioned in the following table.
Supplementary 
TISSUE SECTIONS
Dissection of thoracic muscle tissue and ovary tissue
Adult wild type drosophila flies were collected which were maintained in 12 h light and 12 h dark at 25°C. Once collected, flies were kept in ice for around 15 minutes for anesthetizing.
Thoracic muscle dissection 1. After flies were anesthetized, they were submerged in PBS placed dorsally on the dissection plate and were pierced with insect pins on the abdomen region.
2. Using forceps, top layer of thorax was dissected slowly, peeled out gently and bunch of clustered thoracic muscles were taken out. Protocol for Sequential multiplexed imaging 8. Excess fluorophores were removed by 2 times washing followed by centrifuged at 2000 rcf for 2 min at 4°C. 9. Cy5 stained cells were transferred to the 8-well chamber slide after dilution to 200 µl using PBS (pH 7.4) and structured illumination images were captured immediately using 642 nm laser.
Protocol for bright field immunofluorescence microscopy and FACS analysis
1. Immunostaining of live cells were done by following previously mentioned protocol.
2. For control I, primary antibody incubation step was omitted.
3. For control II, both primary and secondary antibody incubation steps were omitted.
4. Three differently labelled cells were transferred to 8-well chamber slide system and bright field immunofluorescence microscopic images were captured immediately using a motorized inverted microscope (IX81, Olympus, Tokyo, Japan) equipped with a CCD camera (FVII with CellP software, Olympus, Tokyo, Japan). [7] with an affinity of ~10-7 M -1 (K d ) whereas ADA posses an affinity of ~10 -13 M -1 (K d ) towards CB [7] . Therefore, the initial complex between HMD-CB [7] can be disassembled by presentation of the orthogonal guest molecule 1-adamantylamine (ADA), which has relatively high affinity for CB [7] . This guest exchange process leads to the formation of more stable CB[7]-ADA complex, leading to efficient target labeling.
For
Host−Guest mediated live cell actin labeling protocol:
5. Excess imager was removed by washing with DBPS and cells were imaged by keeping them in phenol red free culture medium. For long term live cell imaging, cells were kept at 37°C in a humid atmosphere (5% CO 2 ) by using incubator that is attached with the fluorescence microscope.
Caption for Supporting Movie 1:
Live cell actin dynamics via CB [7] −ADA mediated labeling.
